Endoscopic and electroporation therapy of paranasal sinus tumors

American Journal of Rhinology

Volumn 14, Issue 3, 2000, Pages 187-191

  Panje, William R ^a,b   Sadeghi, Nader ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN;

AGED; ARTICLE; CASE REPORT; CELL MEMBRANE PERMEABILITY; ELECTROCHEMOTHERAPY; ELECTROPORATION; ENDOSCOPIC THERAPY; HUMAN; MALE; NOSE CANCER; PARANASAL SINUS CANCER; TREATMENT OUTCOME;

EID: 0033920604     PISSN: 10506586     EISSN: None     Source Type: Journal    
DOI: 10.2500/105065800782102744     Document Type: Article

References (23)

1. Homer JJ, Jones NS, and Bradley PJ. The role of endoscopy in the management of nasal neoplasia. Am J Rhinol 11:41-17, 1997.
2. Orlowski S, Belehradek J, Jr, Paoletti C, et al. Transient electropermeabilization of cells in culture. Biochem Pharmacol 37: 4727-4733, 1988.
3. Okino M, Marumoto M, Kanesada H, et al. Electrical impulse chemotherapy for rat solid tumors. Proc Jpn Cancer Congress 46:420, 1987.
4. Okino M, and Esato K. The effects of a single high voltage electrical stimulation with anticancer drug on in vivo growing malignant tumors. Jpn J Surg 20:197-204, 1990.
5. Kanesada H. Anticancer effect of high voltage pulses combined with concentration dependent anticancer drugs on Lewis lung carcinoma J Jpn Soc Cancer Ther 25:2640-2648, 1990.
6. Mir LM, Orlowski S, Belehradek J Jr., et al. Electrochemotherapy: potentiation of anti-tumor effect of bleomycin by local electric pulses Eur J Cancer 27:68-72, 1991.
7. Okino M, Tomie H, Kanesada H, et al. Induction of tumor specific selective toxicity in electrical impulse chemotherapy analysis of dose response curve. Oncologia 24:71-79, 1991.
8. Okino M, Tomie H, Kanesada H, et al. Optimal electric conditions in electrical impulse chemotherapy. Jpn J Cancer Res 83:1095-1101, 1992.
9. Weaver JC. Electroporation: a general phenomenon for manipulating cells and tissues. J Cell Biochem 51:426-135, 1993.
10. Salford LG, Persson BRR, Brun A, et al. A new brain tumor therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun 194:938-943, 1993.
11. Sersa G, Cemazar M, Miklavcic D, et al. Electrochemotherapy: variable antitumor effect on different tumor models. Bioelectrochem Bioenerget 35:23-27, 1994.
12. Yamaguchi O, Irisawa C, Baba K, et al. Potentiation of antitumor effect of bleomycin by local electric pulses in mouse bladder tumor. Tohoku J Exp Med 172:291-293, 1994.
13. Dev SB, and Hofmann GA. Electrochemotherapy - a novel method of cancer treatment. Cancer Treat Rev 20:105-115, 1994.
14. Heller R, Jaroszeski M, Leo-Messina J, et al. Treatment of B16 melanoma with the combination of electroporation and chemotherapy. Bioelectrochem Bioenerget 36:83-87, 1995.
15. Mir LM, Belehradek M, Domenge C, et al. Electrochemotherapy, a novel antitumor treatment: first clinical trial. CR Acad Sci Paris 313:613-618, 1991.
16. Heller R, Jaroszeski MJ, Glass LF, et al. Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 77:964-971, 1996.
17. Glass LF, Fenske NA, Jaroszeski M, et al. Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Denn 34:82-86, 1996.
18. Glass LF, Pepine ML, Fenske NA, et al. Bleomycin-mediated electrochemotherapy of metastatic melanoma. Arch Dermatol 132:1353-1357, 1996.
19. Glass LF, Jaroszeski M, Gilbert R, et al. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Denn 39:596-599, 1997.
20. Sikic BI. Biochemical and cellular determinants of bleomycin cytotoxicity. Cancer Surv 5:81-91, 1986.
21. Roy SN, and Horwits SB. Characterization of the association of the radiolabeled bleomycin A2 with Hela cells. Cancer Res. 44:1541-1546, 1984.
22. Bhattacharyya N, Shapiro NL, and Metson R. Endoscopic resection of a recurrent sinonasal hemangiopericytoma. Am J Otolaryngol 18:341-344, 1997.
23. Panje WR, Hier M, Garman GR, et al. Electroporation therapy of head and neck cancer. Ann Otol Rhinol Laryngol. 107:779-785, 1998.